title: HIV-1 group O resistance pathway with raltegravir is similar to HIV-1 group M.
authors.affiliation: aLaboratoire de virologie, associé au Centre National de Référence du VIH, Hôpital Charles Nicolle, CHU de Rouen bGRAM EA2656, Faculté de Médecine-Pharmacie, Université de Rouen, Rouen cService de Médecine Interne A, AP-HP, Hôpital Lariboisière, Université Paris Diderot, Sorbonne Paris Cité dLaboratoire de Virologie, AP-HP, Hôpital Saint-Louis, Université Paris Diderot, Sorbonne Paris Cité eINSERM U941, Hôpital Saint-Louis fLaboratoire de Pharmacologie, AP-HP, Hôpital Bichat, Université Paris Diderot, Sorbonne Paris Cité, Paris, France.
authors.forename: Elodie
authors.initials: E
authors.lastname: Alessandri-Gradt
authors.forename: Marjolaine
authors.initials: M
authors.lastname: Morgand
authors.forename: Constance
authors.initials: C
authors.lastname: Delaugerre
authors.forename: Gilles
authors.initials: G
authors.lastname: Peytavin
authors.forename: Pierre
authors.initials: P
authors.lastname: Sellier
authors.forename: François
authors.initials: F
authors.lastname: Simon
authors.forename: Jean-Christophe
authors.initials: JC
authors.lastname: Plantier
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000494:pharmacology* / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods; D018791:CD4 Lymphocyte Count; D024882:Drug Resistance, Viral; D005260:Female; D005838:Genotype; D015658:HIV Infections / Q000188:drug therapy / Q000821:virology*; D019427:HIV Integrase / Q000235:genetics; D015497:HIV-1 / Q000145:classification* / Q000187:drug effects* / Q000235:genetics / Q000302:isolation & purification; D006801:Humans; D020125:Mutation, Missense; D000068898:Raltegravir Potassium / Q000494:pharmacology* / Q000627:therapeutic use; D016896:Treatment Outcome; D019562:Viral Load
chemical_list: D019380:Anti-HIV Agents; D000068898:Raltegravir Potassium; D019427:HIV Integrase; C514801:p31 integrase protein, Human immunodeficiency virus 1